The U.S. cosmetics regulatory landscape has entered a new era with the implementation of the Modernization of Cosmetics Regulation Act (MoCRA). This legislation significantly strengthens FDA oversight, introducing new obligations for cosmetic manufacturers, brand owners, and distributors selling products on the U.S. market. As a result, companies must now adopt a more structured and proactive compliance strategy to ensure uninterrupted market access.
MOCRA Services for US are designed to support cosmetic brands at every stage of regulatory compliance, from formula evaluation and labeling review to product listing, safety substantiation, and facility registration. These services help companies align with FDA expectations while reducing regulatory risk and administrative burden.
Formula Review and Product Safety Substantiation
Under MoCRA, cosmetic products placed on the U.S. market must be supported by adequate safety substantiation. This requires manufacturers to demonstrate that their products are safe under labeled or customary conditions of use. A comprehensive formula review is therefore a critical first step.
Formula assessments focus on ingredient compliance, restricted substances, concentration limits, and potential toxicological concerns. This process ensures that formulations meet FDA requirements and can be confidently supported by a documented product safety substantiation, as required by MoCRA. Without this documentation, products may face enforcement actions or removal from the market.
Labeling Review and U.S. State Legislation Awareness
Accurate labeling remains one of the most visible and enforceable aspects of cosmetic compliance. MoCRA reinforces labeling obligations while U.S. state-level regulations—such as those in California—introduce additional complexity.
A professional labeling review evaluates ingredient declarations, claims, warnings, and formatting to ensure consistency with FDA regulations and applicable state laws. In parallel, monitoring USA cosmetics state legislations helps brands stay compliant in jurisdictions with enhanced disclosure or reporting requirements. This dual-level approach prevents costly relabeling and minimizes exposure to regulatory scrutiny.
US Responsible Person and US Agent Services
MoCRA formally introduces the role of the Responsible Person, who is accountable for product compliance, adverse event reporting, and communication with the FDA. For non-U.S. manufacturers, fulfilling this role internally is often impractical.
Through US Responsible Person Support and US Agent Service, international brands gain a reliable U.S.-based regulatory presence. This ensures that FDA communications are handled professionally, deadlines are met, and compliance obligations are fulfilled without disrupting business operations.
Product Listing and Facility Registration
MoCRA mandates product listing and facility registration with the FDA, significantly increasing transparency across the cosmetics supply chain. Facilities involved in manufacturing or processing cosmetic products for the U.S. market must be registered, and each product must be properly listed with required information.
Managing these submissions accurately is essential, as errors or omissions can trigger FDA follow-ups or enforcement actions. Centralized regulatory support simplifies this process and ensures that submissions remain up to date as product portfolios evolve.
Integrated MOCRA Compliance Strategy
What distinguishes effective MOCRA Services for US is the ability to integrate all regulatory requirements into a single, coherent compliance framework. Rather than addressing obligations in isolation, brands benefit from a structured approach that aligns formulation, labeling, safety documentation, registration, and post-market responsibilities.
This integrated model reduces internal workload, shortens response times, and provides regulatory clarity—particularly for companies managing multiple products or operating across several markets.
Expert Regulatory Support for the U.S. Market
CE.way provides comprehensive MoCRA-focused regulatory services for cosmetic brands targeting the U.S. market. With experience supporting international manufacturers, CE.way offers expert guidance across formula review, labeling compliance, safety substantiation, FDA submissions, and responsible person services.
For cosmetic companies navigating the evolving U.S. regulatory environment, structured MoCRA compliance is no longer optional—it is a business-critical requirement. With the right regulatory partner and a well-defined compliance strategy, brands can ensure market continuity, regulatory confidence, and long-term growth in the United States.
